Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Protara Therapeutics Inc. (TARA)

17.015   0.185 (1.1%) 10-01 15:43
Open: 16.87 Pre. Close: 16.83
High: 17.04 Low: 16.8
Volume: 14,535 Market Cap: 179M
Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Its product pipeline includes TARA 002 and IV choline chloride for injection. TARA 002 is its lead program focused on the treatment of Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. IV choline chloride is an enzyme replacement therapy for patients with choline deficiency who exhibit symptoms of liver impairment. IV Choline Chloride is being developed for the treatment of Intestinal Failure Associated Liver Disease (IFALD).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.029 - 17.11 17.11 - 17.184
Low: 16.497 - 16.593 16.593 - 16.68
Close: 16.673 - 16.83 16.83 - 16.971

Technical analysis

as of: 2020-10-01 3:39:47 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 24.22     One year: 27.74
Support: Support1: 15.86    Support2: 13.20
Resistance: Resistance1: 20.74    Resistance2: 23.75
Pivot: 17.70
Moving Average: MA(5): 16.86     MA(20): 17.94
MA(100): 27.80     MA(250): 23.81
MACD: MACD(12,26): -1.48     Signal(9): -1.61
Stochastic oscillator: %K(14,3): 15.95     %D(3): 15.47
RSI: RSI(14): 30.82
52-week: High: 67.08  Low: 8.80  Change(%): 63.0
Average Vol(K): 3-Month: 3383  10-Days: 9704

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TARA has closed above bottom band by 33.3%. Bollinger Bands are 67.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to TARA's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 29 Sep 2020
Could The Protara Therapeutics, Inc. (NASDAQ:TARA) Ownership Structure Tell Us Something Useful? - Simply Wall St

Mon, 28 Sep 2020
What Type Of Shareholders Make Up Protara Therapeutics, Inc.'s (NASDAQ:TARA) Share Registry? - Yahoo Finance

Wed, 23 Sep 2020
Insider Buys Protara Therapeutics Shares - Yahoo Finance

Wed, 23 Sep 2020
Form 424B5 Protara Therapeutics, - streetinsider.com

Tue, 22 Sep 2020
Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock - GlobeNewswire

Mon, 21 Sep 2020
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 6
Shares Float (M) 1
% Held by Insiders 20.67
% Held by Institutions 57.25
Shares Short (K) 52
Shares Short P. Month (K) 62

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -20.65

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.